COVID-19 booster for 12-15 year olds approved by FDA

The EUA for the Pfizer-BioNTech COVID-19 vaccine has been updated to include children between the ages of 12 and 15 years old by the Food and Drug Administration (FDA).

A Pfizer-BioNTech booster dose will be given at least five months after the first immunization, according to FDA authorities.

Some immunocompromised children aged 5 to 11 will be able to get booster doses under the amended EUA.

Acting FDA Commissioner Dr. Janet Woodcock said in a statement that the agency has had to fast adapt to the evolving virus that causes COVID-19 because of the need to make informed decisions with the health and safety of the American public in mind throughout the pandemic.

Woodcock underlined the necessity of maintaining long-standing disease preventive practices.

This latest wave of the Omicron variety calls on us to maintain lifesaving preventative measures including primary vaccine and boosters, mask-wearing, social distancing, etc. in order to effectively battle COVID-19, she stated.

Pexel photo